Francis Patrick Ostronic is Director at Cyclo Therapeutics, Inc. (CYTH). They have made 25 open-market trades across 2 companies since 2015, most recently 2025-02-27.
CIK 0001570620
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
25 open-market purchases totalling $747K since 2015, never a sale. Across 18 scored buys the stock is down 7.0% at ninety days, and 6.2 points behind the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 33% |
| Avg Move | -3.5% | -6.7% | -7.0% |
| Alpha | -3.8% | -6.2% | -6.2% |
| Scored | 18 | 18 | 18 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYTH | BUY | 2023-04-20 | 2023-04-24 | $0.71 | $43K | +60.7% | +63.1% | +65.6% |
| CYTH | BUY | 2022-09-21 | 2022-09-22 | $1.76 | $9K | +20.7% | +6.8% | -4.5% |
| CYTH | BUY | 2022-05-20 | 2022-05-23 | $2.04 | $10K | +7.9% | +5.1% | +15.3% |
| CYTH | BUY | 2022-01-24 | 2022-01-24 | $3.75 | $8K | -4.7% | -10.2% | -17.1% |
| CYTH | BUY | 2022-01-19 | 2022-01-19 | $4.00 | $5K | -8.0% | -16.0% | -29.8% |
| CYTH | BUY | 2022-01-14 | 2022-01-14 | $4.00 | $9K | -14.8% | -21.2% | -34.1% |
| CYTH | BUY | 2022-01-14 | 2022-01-18 | $4.00 | $7K | -11.5% | -17.3% | -34.4% |
| CYTH | BUY | 2021-12-15 | 2021-12-15 | $3.90 | $12K | -13.5% | +5.7% | -34.7% |
| CYTH | BUY | 2021-12-10 | 2021-12-10 | $4.40 | $22K | -10.3% | -8.3% | -25.1% |
| CYTH | BUY | 2021-12-03 | 2021-12-06 | $4.75 | $4K | -20.0% | -15.2% | -26.8% |
| CYTH | BUY | 2021-12-02 | 2021-12-02 | $4.75 | $20K | -20.0% | -19.0% | -33.1% |
| CYTH | BUY | 2021-12-01 | 2021-12-01 | $5.00 | $25K | -14.9% | -25.4% | -34.2% |
| CYTH | BUY | 2021-11-19 | 2021-11-19 | $5.25 | $56K | -5.1% | -21.1% | -35.6% |
| CYTH | BUY | 2021-10-29 | 2021-11-01 | $5.90 | $6K | +15.4% | -21.2% | -39.6% |
| CYTH | BUY | 2021-04-16 | 2021-04-16 | $6.53 | $65K | +16.8% | +0.3% | +28.2% |
| CYTH | BUY | 2021-04-12 | 2021-04-12 | $7.00 | $35K | +2.3% | +3.0% | +34.8% |
| CYTH | BUY | 2021-03-29 | 2021-03-30 | $7.53 | $23K | -17.5% | -1.1% | +28.5% |
| CYTH | BUY | 2020-12-17 | 2020-12-17 | $4.66 | $140K | -46.6% | -28.6% | +51.0% |
| CTDH | BUY | 2020-04-24 | 2020-04-27 | $0.10 | $100K | N/A | N/A | N/A |
| CTDH | BUY | 2019-09-16 | 2019-09-18 | $0.19 | $19K | N/A | N/A | N/A |
| CTDH | BUY | 2019-09-11 | 2019-09-13 | $0.18 | $180 | N/A | N/A | N/A |
| CTDH | BUY | 2019-08-22 | 2019-08-29 | $0.20 | $10K | N/A | N/A | N/A |
| CTDH | BUY | 2019-08-01 | 2019-08-02 | $0.23 | $47K | N/A | N/A | N/A |
| CTDH | BUY | 2019-07-31 | 2019-07-31 | $0.25 | $25K | N/A | N/A | N/A |
| CTDH | BUY | 2015-07-10 | 2015-07-14 | $0.50 | $50K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.